|158.10||-0.2400||-0.15%||Vol 576.60K||1Y Perf 20.99%|
|Jun 16th, 2021 12:47 DELAYED|
|- -%||- -|
|Target Price||187.76||Analyst Rating||Moderate Buy 1.56|
|Potential %||18.36||Finscreener Ranking||★+ 44.69|
|Insiders Trans % 3/6/12 mo.||100/100/-33||Value Ranking||★ 40.29|
|Insiders Value % 3/6/12 mo.||100/100/-93||Growth Ranking||★★+ 48.75|
|Insiders Shares Cnt. % 3/6/12 mo.||100/100/-94||Income Ranking||+ 29.65|
|Market Cap||32.96B||Earnings Rating||Buy|
|Price Range Ratio 52W %||67.44||Earnings Date||3rd Aug 2021|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Sell|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||3rd Aug 2021|
|Estimated EPS Next Report||1.84|
|EPS Growth Next 5 Years %||8.90|
|Avg. Weekly Volume||1.03M|
|Avg. Monthly Volume||1.20M|
|Avg. Quarterly Volume||1.05M|
Zimmer Biomet Holdings Inc. (NYSE: ZBH) stock closed at 158.34 per share at the end of the most recent trading day (a 0.5% change compared to the prior day closing price) with a volume of 1.38M shares and market capitalization of 32.96B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 20000 people. Zimmer Biomet Holdings Inc. CEO is Bryan C. Hanson.
The one-year performance of Zimmer Biomet Holdings Inc. stock is 20.99%, while year-to-date (YTD) performance is 2.76%. ZBH stock has a five-year performance of 35.94%. Its 52-week range is between 112 and 180.36, which gives ZBH stock a 52-week price range ratio of 67.44%
Zimmer Biomet Holdings Inc. currently has a PE ratio of 58.20, a price-to-book (PB) ratio of 2.65, a price-to-sale (PS) ratio of 4.63, a price to cashflow ratio of 32.90, a PEG ratio of 2.32, a ROA of 2.22%, a ROC of 3.33% and a ROE of 4.53%. The company’s profit margin is 8.25%, its EBITDA margin is 24.20%, and its revenue ttm is $7.09 Billion , which makes it $34.00 revenue per share.
Of the last four earnings reports from Zimmer Biomet Holdings Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $1.84 for the next earnings report. Zimmer Biomet Holdings Inc.’s next earnings report date is 03rd Aug 2021.
The consensus rating of Wall Street analysts for Zimmer Biomet Holdings Inc. is Moderate Buy (1.56), with a target price of $187.76, which is +18.36% compared to the current price. The earnings rating for Zimmer Biomet Holdings Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Zimmer Biomet Holdings Inc. has a dividend yield of 0.61% with a dividend per share of $0.96 and a payout ratio of 564.00%.
Zimmer Biomet Holdings Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 10.50, ATR14 : 2.76, CCI20 : -77.74, Chaikin Money Flow : -0.18, MACD : -2.90, Money Flow Index : 42.27, ROC : -5.54, RSI : 35.09, STOCH (14,3) : 18.32, STOCH RSI : 0.98, UO : 44.75, Williams %R : -81.68), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Zimmer Biomet Holdings Inc. in the last 12-months were: Arthur J. Higgins (Buy at a value of $171 580), Bryan C. Hanson (Option Excercise at a value of $0), Carrie A. Nichol (Option Excercise at a value of $0), Chad F. Phipps (Option Excercise at a value of $1 805 404), Chad F. Phipps (Sold 30 040 shares of value $4 797 388 ), Didier Deltort (Option Excercise at a value of $0), Ivan Tornos (Option Excercise at a value of $0), Rachel Ellingson (Option Excercise at a value of $0), Sang Yi (Option Excercise at a value of $0), Sang Yi (Sold 1 200 shares of value $183 108 ), Suketu Upadhyay (Option Excercise at a value of $0)
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.